PPLPHARMA2023-05-032023-07-31Resolution1 PPLPHARMA2023-07-31 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution1in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution1 PPLPHARMA2023-05-032023-07-31Resolution2 PPLPHARMA2023-07-31 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution2in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution2 PPLPHARMA2023-05-032023-07-31Resolution3 PPLPHARMA2023-07-31 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution3in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution3 PPLPHARMA2023-05-032023-07-31Resolution4 PPLPHARMA2023-07-31 Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution4in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution4 PPLPHARMA2023-05-032023-07-31Resolution5 PPLPHARMA2023-07-31 Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution5in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution5 PPLPHARMA2023-05-032023-07-31Resolution6 PPLPHARMA2023-07-31 Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution6in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution6 PPLPHARMA2023-05-032023-07-31Resolution7 PPLPHARMA2023-07-31 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember PPLPHARMA2023-07-31 Resolution7in-bse-voting:TotalShareholdingMember PPLPHARMA2023-07-31 Resolution7 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PPLPHARMA INE0DK501011 Piramal Pharma Limited AGM 2023-07-31 296610 0 0 15 105 7 Ordinary false Adoption of Audited Financial Statements (Standalone and Consolidated) and the Reports of the Board of Directors and Auditors thereon of the Company for the financial year ended on March 31, 2023 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 451986790 93.69 451986790 0 100 0 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 451986790 93.69 451986790 0 100 0 295782732 23270818 7.87 23258580 12238 99.95 0.05 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23270818 7.87 23258580 12238 99.95 0.05 1193318500 890375444 74.61 890363206 12238 100 0 Ordinary false Re-appointment of Mr. Neeraj Bhardwaj, who retires by rotation and being eligible, seeks reappointment 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 452306346 93.76 433121043 19185303 95.76 4.24 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 452306346 93.76 433121043 19185303 95.76 4.24 295782732 23271647 7.87 23223211 48436 99.79 0.21 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23271647 7.87 23223211 48436 99.79 0.21 1193318500 890695829 74.64 871462090 19233739 97.84 2.16 Special false Re-appointment of Mr. Peter DeYoung as Executive Director of the Company. 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 452306346 93.76 411376630 40929716 90.95 9.05 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 452306346 93.76 411376630 40929716 90.95 9.05 295782732 23267531 7.87 23229988 37543 99.84 0.16 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23267531 7.87 23229988 37543 99.84 0.16 1193318500 890691713 74.64 849724454 40967259 95.4 4.6 Special false Re-appointment of Ms. Nandini Piramal as Chairperson of the Company 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 452306346 93.76 397485324 54821022 87.88 12.12 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 452306346 93.76 397485324 54821022 87.88 12.12 295782732 23267251 7.87 23228536 38715 99.83 0.17 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23267251 7.87 23228536 38715 99.83 0.17 1193318500 890691433 74.64 835831696 54859737 93.84 6.16 Special false Amendment of Articles of Association of the Company 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 452306346 93.76 450576419 1729927 99.62 0.38 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 452306346 93.76 450576419 1729927 99.62 0.38 295782732 23267250 7.87 23234830 32420 99.86 0.14 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23267250 7.87 23234830 32420 99.86 0.14 1193318500 890691432 74.64 888929085 1762347 99.8 0.2 Special false Issue of Non-Convertible Debentures on Private Placement Basis 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 452306346 93.76 448708357 3597989 99.2 0.8 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 452306346 93.76 448708357 3597989 99.2 0.8 295782732 23267199 7.87 23227516 39683 99.83 0.17 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23267199 7.87 23227516 39683 99.83 0.17 1193318500 890691381 74.64 887053709 3637672 99.59 0.41 Ordinary false Ratification of remuneration payable to Cost Auditors 415122772 415117836 100 415117836 0 100 0 415122772 0 0 0 0 0 0 415122772 0 0 0 0 0 0 415122772 415117836 100 415117836 0 100 0 482412996 452306346 93.76 452306346 0 100 0 482412996 0 0 0 0 0 0 482412996 0 0 0 0 0 0 482412996 452306346 93.76 452306346 0 100 0 295782732 23267143 7.87 23235380 31763 99.86 0.14 295782732 0 0 0 0 0 0 295782732 0 0 0 0 0 0 295782732 23267143 7.87 23235380 31763 99.86 0.14 1193318500 890691325 74.64 890659562 31763 100 0